30 May, 2026

Eli Lilly to acquire three small vaccine developers

Andrew covers the biopharmaceutical industry, scientific research and public health across the continent. You can reach Andrew confidentially on Signal at drawqjoseph.71. Eli Lilly announced Tuesday that it would buy three early- and mid-stage vaccine developers, giving the field a boost. The deals — which together could cost nearly $4 billion — are the latest […]

2 mins read

Pfizer wins over Novo to acquire obesity start-up Metsera

Pfizer won the bidding war against Novo Nordisk to acquire Metsera, a biotech specializing in obesity drugs. The pharmaceutical giant increased its offer, valuing the startup at around $10 billion, Metsera announced Friday. In a statement, the biotech also said it received a call from the Federal Trade Commission regarding the potential risks of Novo’s […]

4 mins read